FRAMINGHAM, MA
4 risk indicators measuring financial stability and operational resilience
Sign in with your work email to view Tuckman-Chang indicators
Sign In — Free (10 views/day)BOSTON BIOSTATISTICS RESEARCH FOUNDATION INC, founded in 1988, is a community nonprofit in the Science & Technology sector that reported $1.1M in total revenue in fiscal year 2023. Revenue fell 24% from the prior year — a significant decline worth monitoring. The organization ran a surplus of $354K, a strong 32% operating margin.
STATISTICAL MEDICAL RESEARCH
BOSTON BIOSTATISTICS RESEARCH FOUNDATIONS INC. PERFORMED DATA ANALYSES FOR MULTIPLE PUBLIC HEALTH STUDIES INVOLVING BREAST CANCER DIAGNOSIS USING OPTOACOUSTICS; HEAD AND NECK CANCER USING...
BOSTON BIOSTATISTICS RESEARCH FOUNDATIONS INC. PERFORMED DATA ANALYSES FOR MULTIPLE PUBLIC HEALTH STUDIES INVOLVING BREAST CANCER DIAGNOSIS USING OPTOACOUSTICS; HEAD AND NECK CANCER USING IMMUNOTHERAPY, COLORECTAL CANCER SCREENING USING A STOOL-BASED DNA TEST; WEIGHT LOSS FOLLOWING GASTRIC SURGERY, AND KNEE OSTEOARTHRITIS FOLLOWING LUBRICANT INJECTION. THREE PAPERS ON BREAST CANCER IMAGING, HYPERKALEMIA TREATMENT, AND COVID-19 WERE PUBLISHED. FOUR ABSTRACTS WERE ACCEPTED FOR TALKS ON CANCER TREATMENTS. WE HELPED WRITE A GRANT PROPOSAL TO COVER DENTAL IMAGING. WE CONTINUED TO REVIEW PUBLICATIONS FOR MEDICAL JOURNALS. WE CONDUCTED STATISTICAL RESEARCH IN STUDY DESIGN AND ANALYSIS METHODS FOR SCREENING (TO DETECT ASYMPTOMATIC DISEASE EARLIER) AND IMAGING (BUILDING ON TUMOR AND NODE DATA).
Financial Health Score (300–850) · Liquidity · Solvency · Sustainability · Efficiency
Sign in to view Trantor Score and financial metrics
Liquidity (40%) • Solvency (30%) • Sustainability (20%) • Efficiency (10%)
Sign In — Free (10 views/day)| 2023 | 2022 | Change | |
|---|---|---|---|
| Revenue | $1,101,919 | $1,455,633 | -0.2% |
| Expenses | $747,826 | $671,929 | +0.1% |
| Net Income | $354,093 | $783,704 | -0.5% |
Comprehensive financial analysis: Altman Z-Score, liquidity, solvency, sustainability, efficiency, and growth metrics
Financial Distress Indicator
Liquidity & Cash Position
Sign in to view all financial metrics
Altman Z-Score • Liquidity Ratios • Solvency Analysis • Growth Indicators • Efficiency Metrics
Sign In| Name | Title | Hours/Week | Role | Reportable Comp | Other Comp | Total |
|---|---|---|---|---|---|---|
| PHILIP T LAVIN | PRES/TREAS/C | 20.00 |
Officer
|
$216,000 | $25,990 | $241,990 |
| Year | Revenue | Expenses | Assets | Net Income |
|---|---|---|---|---|
| 2024 | No data | No data | No data | No data |
| 2023 | $1,101,919 | $747,826 | $13,112,195 | $354,093 |
| 2022 | $1,455,633 | $671,929 | $12,758,102 | $783,704 |
| 2021 | $1,996,157 | $604,631 | $12,036,898 | $1,391,526 |
| 2020 | $2,033,389 | $962,050 | $10,582,872 | $1,071,339 |
| 2019 | $1,731,316 | $854,882 | $9,511,533 | $876,434 |
| 2018 | $1,957,695 | $913,989 | $8,635,099 | $1,043,706 |
Compare BOSTON BIOSTATISTICS RESEARCH FOUNDATION INC with other nonprofits in Massachusetts and across the country.